Long-term clinical course and outcome of schizophrenia in rural Ethiopia: 10-year follow-up of a population-based cohort

Schizophrenia Research

Volumn 161, Issue 2-3, 2015, Pages 414-420

  Shibre, Teshome ^a,b   Medhin, Girmay ^a   Alem, Atalay ^a   Kebede, Derege ^a,c   Teferra, Solomon ^a   Jacobsson, Lars ^d   Kullgren, Gunnar ^d   Hanlon, Charlotte ^a,e   Fekadu, Abebaw ^a,e  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

^b UNIVERSITY OF TORONTO   (Canada)

^c WHO REGIONAL OFFICE FOR AFRICA   (Congo)

^d UMEÅ UNIVERSITY   (Sweden)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Course; Ethiopia; Follow up study; Gender; Outcome; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; DRUG TOLERABILITY; ETHIOPIA; FEMALE; FOLLOW UP; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; OUTCOME ASSESSMENT; POPULATION RESEARCH; PREDICTIVE VALUE; REMISSION; RURAL AREA; SCHIZOPHRENIA; SEX DIFFERENCE; AKATHISIA, DRUG-INDUCED; DISEASE COURSE; LONGITUDINAL STUDY; MIDDLE AGED; ONSET AGE; RURAL POPULATION; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; AGE OF ONSET; AKATHISIA, DRUG-INDUCED; ANTIPSYCHOTIC AGENTS; DISEASE PROGRESSION; ETHIOPIA; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; REMISSION INDUCTION; RURAL POPULATION; SCHIZOPHRENIA; SEX FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84921491946     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.10.053     Document Type: Article

References (55)

1. Abbas S.M., Alam A.Y., Majid A. To determine the probable causes of death in an urban slum community of Pakistan among adults 18years and above by verbal autopsy. J. Pak. Med. Assoc. 2011, 61(3):235-238.
2. Addington D.E., Toews J.A., Addington J.M. Risperidone and tardive dyskinesia: a case report. J. Clin. Psychiatry 1995, 56(10):484-485.
3. Alem A., Kebede D., Fekadu A., et al. Clinical course and outcome of schizophrenia in a predominantly treatment-naive cohort in rural Ethiopia. Schizophr. Bull. 2009, 35(3):646-654.
4. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, Washington, DC. IV ed.
5. Andreasen N.C. Negative versus positive schizophrenia: definition and validation. Arch. Gen. Psychiatry 1982, 39:789-794.
6. Andreasen N.C. Scale for the assessment of negative symptoms/scale for the assessment of positive symptoms [manual] University of Iowa Press 1984, University of Iowa Press, Iowa City. Iowa.
7. Assefa D., Shibre T., Asher L., Fekadu A. Internalized stigma among patients with schizophrenia in Ethiopia: a cross-sectional facility-based study. BMC Psychiatry 2012, 12:239.
8. Bressan R.A., Jones H.M., Pilowsky L.S. Atypical antipsychotic drugs and tardive dyskinesia: relevance of D2 receptor affinity. J. Psychopharmacol. 2004, 18(1):124-127.
9. Burns J. Dispelling a myth: developing world poverty, inequality, violence and social fragmentation are not good for outcome in schizophrenia. Afr. J. Psychiatry 2008, 12:200-205.
10. Cohen A., Patel V., Thara R., Gureje O. Questioning an axiom: better prognosis for schizophrenia in the developing world?. Schizophr. Bull. 2008, 34(2):229-244.
11. Crumlish N., Whitty P., Clarke M., et al. Beyond the critical period: longitudinal study of 8-year outcome in first-episode non-affective psychosis. Br. J. Psychiatry 2009, 194(1):18-24.
12. Farooq S., Large M., Nielssen O., Waheed W. The relationship between the duration of untreated psychosis and outcome in low-and-middle income countries: a systematic review and meta-analysis. Schizophr. Res. 2009, 109(1-3):15-23.
13. Fekadu A., Kebede D., Alem A., et al. Clinical outcome in bipolar disorder in a community-based follow-up study in Butajira-Ethiopia. Acta Psychiatr. Scand. 2006, 114:426-434.
14. Gershanik O.S., Godmez Aredvalo G.J. Typical and atypical neuroleptics. Handb. Clin. Neurol. 2011, 100:579-599.
15. Gureje O., Cohen A. Differential outcome of schizophrenia: where we are and where we would like to be. Br. J. Psychiatry 2011, 199(3):173-175.
16. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960, 23:56-62.
17. Harrison G., Hopper K., Craig T., et al. Recovery from psychotic illness: a 15 and 25-year international follow-up study. Br. J. Psychiatry 2001, 178:506-517.
18. Jablensky A., Sartorius N., Ernberg G., et al. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol. Med. Monogr. Suppl. 1992, 20:1-97.
19. Judd L.L., Akiskal H.S., Schettler P.J., et al. Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study. Arch. Gen. Psychiatry 2005, 62(12):1322-1330.
20. Kebede D., Alem A., Shibre T., et al. Onset and clinical course of schizophrenia in Butajira-Ethiopia-a community-based study. Soc. Psychiatry Psychiatr. Epidemiol. 2003, 38(11):625-631.
21. Kebede D., Alem A., Shibre T., et al. The sociodemographic correlates of schizophrenia in Butajira, rural Ethiopia. Schizophr. Res. 2004, 69(2-3):133-141.
22. Kebede D., Alem A., Shibre T., et al. Short-term symptomatic and functional outcomes of schizophrenia in Butajira, Ethiopia. Schizophr. Res. 2005, 78(2-3):171-185.
23. Keller M.B., Lavori P.W., Friedman B., et al. The longitudinal interval follow-up evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. Arch. Gen. Psychiatry 1987, 44(6):540-548.
24. Kirkpatrick B., Buchanan R.W., Ross D.E., et al. A separate disease within the syndrome of schizophrenia. Arch. Gen. Psychiatry 2001, 58(2):165-171.
25. Koshino Y., Madokoro S., Ito T., et al. A survey of tardive dyskinesia in psychiatric inpatients in Japan. Clin. Neuropharmacol. 1992, 15(1):34-43.
26. Kulhara P., Shah R., Grover S. Is the course and outcome of schizophrenia better in the 'developing' world?. Asian J Psychiatr 2009, 2(2):55-62.
27. Kurihara T., Kato M., Kashima H., et al. Excess mortality of schizophrenia in the developing country of Bali. Schizophr. Res. 2006, 83(1):103-105.
28. Mojtabai R., Varma V.K., Malhotra S., et al. Mortality and long-term course in schizophrenia with a poor 2-year course: a study in a developing country. Br. J. Psychiatry 2001, 178(1):71-75.
29. Murphy H.B., Raman A.C. The chronicity of schizophrenia in indigenous tropical people. Results of a twelve-year follow-up survey in Mauritius. Br. J. Psychiatry 1971, 118(546):489-497.
30. Nielsen J., le Quach P., Emborg C., et al. 10-year trends in the treatment and outcomes of patients with first-episode schizophrenia. Acta Psychiatr. Scand. 2010, 122(5):356-366.
31. Novick D., Haro J.M., Hong J., et al. Regional differences in treatment response and three year course of schizophrenia across the world. J. Psychiatr. Res. 2012, 46(7):856-864.
32. Ohaeri J.U. Long-term outcome of treated schizophrenia in a Nigerian cohort. Retrospective analysis of 7-year follow-ups. J. Nerv. Ment. Dis. 1993, 181(8):514-516.
33. Patel V., Cohen A., Thara R., Gurege O. Is the outcome of schizophrenia really better in developing countries?. Rev. Psiquiatr. 2006, 28(2):149-152.
34. Perkins D.O., Gu H., Boteva K., Lieberman J.A. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am. J. Psychiatry 2005, 162(10):1785-1804.
35. Ran M.S., Chen E.Y., Conwell Y., et al. Mortality in people with schizophrenia in rural China: 10-year cohort study. Br. J. Psychiatry 2007, 190:237-242.
36. Sartorius N., Janca A. Psychiatric assessment instruments developed by the World Health Organization. Soc. Psychiatry Psychiatr. Epidemiol. 1996, 31(2):55-69.
37. Sartorius N., Jablensky A., Shapiro R. Two-year follow-up of the patients included in the WHO International Pilot Study of Schizophrenia. Psychol. Med. 1977, 7:529-541.
38. Sartorius N., Jablensky A., Shapiro R. Cross-cultural differences in the short-term prognosis of schizophrenic psychoses. Schizophr. Bull. 1978, 4(1):102-113.
39. Shibre T., Kebede D., Alem A., et al. An evaluation of two screening methods to identify cases with schizophrenia and affective disorders in a community survey in rural Ethiopia. Int. J. Soc. Psychiatry 2002, 48(3):200-208.
40. Shibre T., Kebede D., Alem A., Kebreab S., et al. Neurological soft signs (NSS) in 200 treatment-naive cases with schizophrenia: a community-based study in a rural setting. Nord. J. Psychiatry 2002, 56(6):425-431.
41. Shibre T., Kebede D., Alem A., et al. Schizophrenia: illness impact on family members in a traditional society-rural Ethiopia. Soc. Psychiatry Psychiatr. Epidemiol. 2003, 38(1):27-34.
42. Shibre T., Hanlon C., Medhin G., et al. Suicide and suicide attempts in people with severe mental disorders in Butajira, Ethiopia: 10year follow-up of a population-based cohort. BMC Psychiatry 2014, 14(150):1-12.
43. Soleman N., Chandramohan D., Shibuya K. Verbal autopsy: current practices and challenges. Bull. World Health Organ. 2006, 84(3):239-245.
44. Taylor D., Panton C., Kapur S. The Moudsley prescribing guideline. Informa Healthcare 2009, Informa Healthcare is the publisher, London, UK. 10th ed.
45. Teferra S., Shibre T., Fekadu A., Medhin G., et al. Five-year mortality in a cohort of people with schizophrenia in Ethiopia. BMC Psychiatry 2011, 11:165. 10.1186/1471-244X-11-165.
46. Teferra S., Hanlon C., Beyero T., et al. Perspectives on reasons for non-adherence to medication in persons with schizophrenia in Ethiopia: a qualitative study of patients, caregivers and health workers. MBC Psychiatry 2013, 13(168):1-9.
47. Tek C., Kirkpatrick B., Buchanan R.W. A five-year follow up study of deficit and non-deficit schizophrenia. Schizophr. Res. 2001, 49(3):253-260.
48. Thara R., Rajkumar S. Gender differences in schizophrenia. Results of a follow-up study from India. Schizophr. Res. 1992, 7(1):65-70.
49. Thara R., Henrietta M., Joseph A., et al. Ten-year course of schizophrenia-the Madras longitudinal study. Acta Psychiatr. Scand. 1994, 90(5):329-336.
50. Ustün B., Compton W., Mager D., Babor T., Baiyewu O., Chatterji S., et al. WHO study on the reliability and validity of alcohol and drug use disorder instruments: overview of methods and results. Drug Alcohol Depend. 1997, 47(3):161-169.
51. Van Zelst C. Stigmatization as an environmental risk in schizophrenia: a user perspective. Schizophr. Bull. 2009, 35(2):293-296.
52. Warshaw M.G., Dyck I., Allsworth J., et al. Maintaining reliability in a long-term psychiatric study: an ongoing inter-rater reliability monitoring program using the longitudinal interval follow-up evaluation. J. Psychiatr. Res. 2001, 35(5):297-305.
53. Wiersma D., Nienhuis F.J., Slooff C.J., Giel R. Natural course of schizophrenic disorders: a 15-year follow up of a Dutch incidence cohort. Schizophr. Bull. 1998, 24(1):75-85.
54. World Health Organization International Statistical Classification of Diseases and Related Health Problems (ICD) 1994, WHO, Geneva.
55. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 1978, 133:429-435.